[PDF] Top 20 Glycemic effects of simvastatin: Where do we stand?
Has 10000 "Glycemic effects of simvastatin: Where do we stand?" found on our website. Below are the top 20 most common "Glycemic effects of simvastatin: Where do we stand?".
Glycemic effects of simvastatin: Where do we stand?
... with simvastatin in T2DM patients to achieve target lipid levels because fibrates do not lead to the worsening of blood glucose ...The simvastatin-fenofibrate combination has been shown to be ... See full document
11
Gender and media: where do we stand today?
... collection of chapters brings a critical overview for the contem- porary interrelations between gender and communication and clearly dem- onstrates the major challenges faced by this area of research, at a ... See full document
7
Ultrasound and its clinical use in rheumatoid arthritis: where do we stand?
... plenty of recent literature looking at the role of MSUS either as a complement to physical examination or as a measure of disease ...patients, where metrics are less reliable (due to ... See full document
10
Eliminating human African trypanosomiasis: where do we stand and what comes next?
... Health Assembly called on member states to sustain the effort to eliminate the disease as a public health problem, which led the WHO programme to intensify its coordinating efforts, bringing together national control ... See full document
7
Aluminium speciation and internal detoxification mechanisms in plants: where do we stand?
... times of Al complexes and allow further investigation by ...tions of plant sap samples obtained by strong anion or cation exchange chromatography were analyzed off-line by ...identity of the Al ... See full document
11
Two decades of "Horse sweat" taint and Brettanomyces yeasts in wine: where do we stand now ?
... The Brettanomyces yeasts are mostly associated with fermented products, particularly with the post-fermentation or aging period of alcoholic beverages, like wine, beer, cider, kombucha, and tequila. Some reports ... See full document
14
← Return to Article Details Structural change and productivity growth in Brazil: where do we stand?
... loss of importance of the manufacturing sector occurs before the econo- my has reached the stage of fully exploiting the scale gains provided by the dynamics of the industrial transformation ... See full document
21
NOD2 mutations and colorectal cancer - Where do we stand?
... total of 85 papers were screened, but only 8 were considered appropriate to be included (all from Caucasian populations), totaling 3524 CRC cases and 2364 controls (Table ...one of these high-risk alleles, ... See full document
11
Mesenchymal stromal cells’ therapy for polyglutamine disorders: where do we stand and where should we go?
... group of inherited neurodegenerative disorders caused by the expansion of the cytosine-adenine-guanine (CAG) ...alteration of its conformation/physiological role and in the formation of toxic ... See full document
25
Treatment of knee OSTEOARTHRITIS in Spa Health resorts: where do we stand?
... the effects of balneo-therapy, the studies considered Visual Analogue Scale for spontaneous pain or WOMAC pain scale, WOMAC functional capacity, Psychosocial status, Depression, WOMAC osteoarthritis index, ... See full document
11
Permanent Pacemaker Post Cardiac Surgery: where do we Stand?
... aetiology of such high PPM requirement is multifactorial, and this includes older age, preoperative comorbidities, such as diabetes mellitus and electrolyte disturbances, impaired ejection fraction, and the ... See full document
12
Solar stereoscopy – where are we and what developments do we require to progress?
... reconstruction of true dynamic phenomena like the initiation of flares and ...If we can then also observe the 3-D- structure of the dynamic phase this would be very helpful for our ... See full document
12
Toxicological effects of a pharmaceutical, simvastatin, in Gammarus locusta: histopathological evaluation
... contaminants of aquatic ecosystems, mostly by inputs from domestic and hospital ...toxicity of pharmaceuticals in the environment is not yet well known, such as for simvastatin, which is a human drug ... See full document
49
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
... prevalence of approximately 10% in people >50 years of ...ossification of ligaments and entheses, especially in the axial skeleton but also in peripheral ...Classification of DISH is being ... See full document
6
Together We Stand, Divided We Fall: A Multidisciplinary Approach in Complicated Acute Pancreatitis
... 35% of patients were successfully treated with percutaneous drainage alone, without subsequent ...95% of patients with infected necrosis can be drained percutaneously, but a promising alternative is ... See full document
9
Patient experience in home respiratory therapies : where we are and where to go
... Training: formal training on appropriate equipment use has been suggested to be an important strategy for improving adherence [ 46 – 51 ]. Healthcare professionals need to introduce the device, explore possible practical ... See full document
24
Pleiotropic effects of simvastatin in physically trained ovariectomized rats
... incidence of cardiovascular disease in women increases sharply after menopause and probably involves changes in BP and its regulation associated with estrogen loss ...study, we showed elevated BP values in ... See full document
7
Metabolic theory and diversity gradients: where do we go from here?
... A global evaluation of metabolic theory as an explanation for terrestrial species richness gradients.. Very high resolution interpolated climate.[r] ... See full document
6
Schistosomiasis epidemiology and control: how did we get here and where should we go?
... Development of drugs took much longer than that of ...acceptance of hycanthone, the first single-dose drug effective against ...1980s of praziquantel, a safe, effective, single-dose drug ... See full document
12
Effects of a structured education program on glycemic control in type 1 diabetes
... group of 6-8 people, we offered a DAFNE-based SEP with group meetings, individual consultations, and remote access on ...demand. We believe that this model of assistance accounted at least ... See full document
8
temas relacionados